Achieve Life Sciences, Inc. (ACHV) vs Geron Corporation (GERN)

A side-by-side comparison of Achieve Life Sciences, Inc. and Geron Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ACHV vs GERN

growth of $100 · dividends reinvested · last 10y
ACHV -99.2% (-38.5%/yr)GERN -44.7% (-5.8%/yr)GERN compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020182020202220242026$1$55
ACHV GERN

ACHV vs GERN: by the numbers

  • •GERN is the larger company ($776M vs $720M market cap).
  • •Both run net losses; ACHV's is the smaller (0.00% vs -34.17% net margin).

Metrics side by side

Valuation

MetricACHVGERN
P/S ratioN/A3.79
P/B ratioN/A3.55

Profitability

MetricACHVGERN
Gross margin0.00%97.42%
Operating margin0.00%-29.28%
Net margin0.00%-34.17%
ROEN/A-31.97%
ROICN/A-8.34%

Growth (annualized)

MetricACHVGERN
Revenue CAGR (5Y)N/A247.85%
Total return CAGR (5Y)-4.33%-1.87%

Frequently asked

How have ACHV and GERN total returns compared?
Over the past 10 years, ACHV delivered -39.18% and GERN delivered -6.18% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.